Probiotics can significantly reduce the levels of serum high-sensitivity C-reactive protein (hs-CRP) and interleukin-6 (IL-6) in peritoneal dialysis (PD) patients, while increasing serum albumin levels, upper arm circumference, and triceps skinfold thickness. The gene discussed is MAP3K14; the disease is Parkinson disease.